Abstract | OBJECTIVE: PATIENTS AND METHODS: Thirty Duke's B and 52 Duke's C patients undergoing resection for colorectal cancer were studied. The median follow-up time was 34.8 months. A pool of 57 sera from normal subjects was used as an Internal Normal Standard (INS). sLe(x) analyses were performed by a thin layer chromatography (TLC) immunostaining technique. Results were expressed as the ratio (R) between bands of INS and bands from each neoplastic serum. RESULTS: The median R value was 0.80 in normal subjects, 0.70 in Duke's B patients and 1.0 in Duke's C patients. No significant differences were detected between sLe(x) concentrations in sera from normal and neoplastic subjects (p = 0.1). Using an arbitrary cutoff of R = 0.9, the mean disease-free interval in the whole series was 47.4 months for R <0.9 and 126.0 months for R > or = 0.9 (p = 0.04). The survival time was 76.8 months for patients with R values <0.9 and 156.3 months for patients with R values > or =0.9 (p = 0.1). CONCLUSIONS: High serum levels of ganglioside sLe(x) significantly correlate with a favorable prognosis and with a lower occurrence of metastases. It is conceivable that soluble sLe(x) may compete with membrane-bound sLe(x) in the course of interactions between activated endothelium and tumor cells that have reached the circulation.
|
Authors | Michela Paganuzzi, Barbara Bobbio, Paola Marroni, Rosa Filiberti, Giovanni Battista Secco, Carlo Enrico Grossi |
Journal | Oncology
(Oncology)
Vol. 65
Issue 1
Pg. 52-9
( 2003)
ISSN: 0030-2414 [Print] Switzerland |
PMID | 12837983
(Publication Type: Journal Article)
|
Copyright | Copyright 2003 S. Karger AG, Basel |
Chemical References |
- Biomarkers, Tumor
- Lewis X Antigen
- Oligosaccharides
- Sialyl Lewis X Antigen
|
Topics |
- Aged
- Biomarkers, Tumor
(blood)
- Case-Control Studies
- Chromatography, Thin Layer
- Colorectal Neoplasms
(blood, mortality, pathology, surgery)
- Disease-Free Survival
- Female
- Humans
- Italy
- Lewis X Antigen
(blood)
- Male
- Neoplasm Metastasis
- Oligosaccharides
(blood)
- Prognosis
- Sialyl Lewis X Antigen
- Survival Analysis
|